The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery
Open accessAbstract
Tumor necrosis factor-α (TNF-α) is a potent cytokine with anticancer efficacy that can significantly enhance hyperthermic injury. However, TNF-α is systemically toxic, thereby creating a need for its selective tumor delivery. We used a newly developed nanoparticle delivery system consisting of 33-nm polyethylene glycol–coated colloidal gold nanoparticles (PT-cAu-TNF-α) with incorporated TNF-α payload (several hundred TNF-α molecules per nanoparticle) to maximize tumor damage and minimize systemic exposure to TNF-α. SCK mammary carcinomas grown in A/J mice were treated with 125 or 250 μg/kg PT-cAu-TNF-α alone or followed by local heating at 42.5°C using a water bath for 60 minutes, 4 hours after nanoparticle injection. Increases in tumor growth delay were observed for both PT-cAu-TNF-α alone and heat alone, although the most dramatic effect was found in the combination treatment. Tumor blood flow was significantly suppressed 4 hours after an i.v. injection of free TNF-α or PT-cAu-TNF-α. Tumor perfusion, imaged by contrast enhanced ultrasonography, on days 1 and 5 after treatment revealed perfusion defects after the injection of PT-cAu-TNF-α alone and, in many regions, complete flow inhibition in tumors treated with combination treatment. The combination treatment of SCK tumors in vivo reduced the in vivo/in vitro tumor cell survival to 0.05% immediately following heating and to 0.005% at 18 hours after heating, suggesting vascular damage–mediated tumor cell killing. Thermally induced tumor growth delay was enhanced by pretreatment with TNF-α-coated gold nanoparticles when given i.v. at the proper dosage and timing. [Mol Cancer Ther 2006;5(4):1014–20]
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Magnetic nanoparticle design for medical diagnosis and therapy
Mornet, S., Vasseur, S., Grasset, F., & Duguet, E. (2004) · Journal of Materials Chemistry · doi:10.1039/b402025a · Cited by 1,745
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Self-citationEffect of local hyperthermia on blood flow and microenvironment: a review.
Song, C. W. (1984) · PubMed · Cited by 628
Self-citationCharacterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature.
Kong, G., Braun, R. D., & Dewhirst, M. W. (2001) · PubMed · Cited by 442
Microenvironmental and cellular consequences of altered blood flow in tumours
Raghunand, N., Gatenby, R. A., & Gillies, R. J. (2003) · The British Journal of Radiology · doi:10.1259/bjr/12913493 · Cited by 240
Senzer, N., Mani, S., Rosemurgy, A., Nemunaitis, J., Cunningham, C., Guha, C., Bayol, N., Gillen, M., Chu, K., Rasmussen, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.227 · Cited by 195
MR Imaging–Controlled Focused Ultrasound Ablation: A Noninvasive Image-Guided Surgery
Jolesz, F. A., Hynynen, K., McDannold, N., & Tempany, C. (2005) · Magnetic Resonance Imaging Clinics of North America · doi:10.1016/j.mric.2005.04.008 · Cited by 193
Brouckaert, P. G. G., Leroux‐Roels, G. G., Guisez, Y., Tavernier, J., & Fiers, W. (1986) · International Journal of Cancer · doi:10.1002/ijc.2910380521 · Cited by 177
Kircheis, R., Ostermann, E., Wolschek, M. F., Lichtenberger, C., Magin-Lachmann, C., Wightman, L., Kursa, M., & Wagner, E. (2002) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700487 · Cited by 90
Cited by
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
Boisselier, E., & Astruc, D. (2009) · Chemical Society Reviews · doi:10.1039/b806051g · Cited by 2,842
Gold nanoparticles in biomedical applications: recent advances and perspectives
Dykman, L., & Khlebtsov, N. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15166e · Cited by 1,961
Kim, B. Y. S., Rutka, J. T., & Chan, W. C. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0912273 · Cited by 1,147
Premanathan, M., Karthikeyan, K., Jeyasubramanian, K., & Manivannan, G. (2011) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2010.10.001 · Cited by 1,098
Selective toxicity of zinc oxide nanoparticles to prokaryotic and eukaryotic systems
Reddy, K. M., Feris, K., Bell, J., Wingett, D. G., Hanley, C., & Punnoose, A. (2007) · Applied Physics Letters · doi:10.1063/1.2742324 · Cited by 979
Metadata
- Authors
- Visaria, R. K., Griffin, R. J., Williams, B. W., Ebbini, E. S., Paciotti, G. F., Song, C. W., & Bischof, J. C.
- Venue
- Molecular Cancer Therapeutics
- Published
- 2006-04-01
- Volume
- 5
- Issue
- 4
- Pages
- 1014-1020
- ISSN
- 1535-7163 (ISSN-L)
- 1538-8514
- OpenAlex
- W2097903633
- Cited by
- 268
- References
- 18
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery. https://app.cochat.ai/papers/10.1158/1535-7163.mct-05-0381
- The paper
- Visaria, R. K., Griffin, R. J., Williams, B. W., Ebbini, E. S., Paciotti, G. F., Song, C. W., & Bischof, J. C. (2006). Enhancement of tumor thermal therapy using gold nanoparticle–assisted tumor necrosis factor-α delivery. Molecular Cancer Therapeutics. https://doi.org/10.1158/1535-7163.mct-05-0381
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.